HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons.
Poloznikov AA, Nersisyan SA, Hushpulian DM, Kazakov EH, Tonevitsky AG, Kazakov SV, Vechorko VI, Nikulin SV, Makarova JA, Gazaryan IG.
Poloznikov AA, et al. Among authors: kazakov eh.
Front Pharmacol. 2021 Jan 29;11:621054. doi: 10.3389/fphar.2020.621054. eCollection 2020.
Front Pharmacol. 2021.
PMID: 33584306
Free PMC article.
Review.